ArticleTherapeutic advances in hematology2012

Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Christos Vaklavas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.